News & Perspective

Aug 31, 2018

Aug 31, 2018

ASP Scan (Weekly) for Aug 31, 2018

C diff testing in the NICU
Resistant gonorrhea in Europe
ESBL bacteria in sprouts
Antibiotic resistance risk factors
Business case for stewardship
UK FMT C diff guidelines
Pharmacist-led stewardship
Typhoid vaccine as stewardship tool
Web training for antibiotic stewardship
Chest x-ray and pneumonia
New antibiotic for intra-abdominal infections
Bedaquiline for MDR-TB
Australian stewardship study

Jul 13, 2018

Jul 13, 2018

ASP Scan (Weekly) for Jul 13, 2018

Stewardship nudge
MDR-TB in kids
Mycoplasma genitalium guidelines
Fluoroquinolone safety update
Kids' fever and antibiotics
Resistant Klebsiella in Europe
Ceftolozane-tazobactam against E coli
UK competition for AMR innovation
Funding for new gonorrhea drug
Antibiotic course for pneumonia
CRE reduction in Israel
Southeast Asian neonatal infections

Mar 23, 2018

Mar 23, 2018

ASP Scan (Weekly) for Mar 23, 2018

Contact precautions and resistance
Antimicrobial use on farms
CARB-X funds antibiotic candidate
Resistance surveillance in poor nations
MDR-TB treatment outcomes
New stewardship e-book
Sepsis, diagnostics technology
Resistant TB in Europe
Appropriate C diff testing
Fast sepsis detection

Sep 22, 2015

Sep 22, 2015
Antibiotic drug pile

Report notes alarming global levels of antibiotic resistance

The CDDEP report and maps provide an unprecedented look at the problem and include a range of data, some public for the first time.

Aug 25, 2008

Aug 25, 2008

H1N1 flu viruses growing more resistant to Tamiflu

(CIDRAP News) – With influenza season well under way in the southern hemisphere, one of the three kinds of seasonal influenza virus is becoming increasingly resistant to the antiviral drug oseltamivir (Tamiflu), the World Health Organization (WHO) reported last week.

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»